Cargando…

Anticancer properties of cannabidiol and Δ(9)-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines

INTRODUCTION: With the legalization of cannabis in multiple jurisdictions throughout the world, a larger proportion of the population consumes cannabis. Several studies have demonstrated anti-tumor effects of components present in cannabis in different models. Unfortunately, little is known about th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whynot, Erin G., Tomko, Andrea M., Dupré, Denis J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985258/ https://www.ncbi.nlm.nih.gov/pubmed/36870996 http://dx.doi.org/10.1186/s42238-023-00174-z

Ejemplares similares

Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer
por: Tomko, Andrea M., et al.
Publicado: (2022)

Toxicological Properties of Δ(9)-tetrahydrocannabinol and Cannabidiol
por: Černe, Katarina
Publicado: (2020)

Continuous-Flow Synthesis of Δ(9)-Tetrahydrocannabinol and Δ(8)-Tetrahydrocannabinol from Cannabidiol
por: Bassetti, Benedetta, et al.
Publicado: (2023)

Single and Synergistic Effects of Cannabidiol and Δ-9-Tetrahydrocannabinol on Zebrafish Models of Neuro-Hyperactivity
por: Samarut, Éric, et al.
Publicado: (2019)

Δ(9)-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure
por: Miller, Sally, et al.
Publicado: (2018)

Cannabidiol Does Not Convert to Δ(9)-Tetrahydrocannabinol in an In Vivo Animal Model
por: Wray, Louise, et al.
Publicado: (2017)

Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
por: Rao, Qianru, et al.
Publicado: (2022)

Combinations of Cannabidiol and Δ(9)-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
por: Sepulveda, Diana E., et al.
Publicado: (2022)

Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial
por: Zamarripa, C. Austin, et al.
Publicado: (2023)

Neuronal and Astrocytic Morphological Alterations Driven by Prolonged Exposure with Δ9-Tetrahydrocannabinol but Not Cannabidiol
por: Landucci, Elisa, et al.
Publicado: (2022)

Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
por: Wakshlag, Joseph J., et al.
Publicado: (2020)

Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation
por: Murkar, Anthony, et al.
Publicado: (2019)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
por: Chetia, Swapnali, et al.
Publicado: (2020)

Individual and combined effects of cannabidiol and Δ(9)-tetrahydrocannabinol on striato-cortical connectivity in the human brain
por: Wall, Matthew B, et al.
Publicado: (2022)

The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice
por: Eitan, Adi, et al.
Publicado: (2023)

Beyond Δ9-tetrahydrocannabinol and cannabidiol: chemical differentiation of cannabis varieties applying targeted and untargeted analysis
por: Monti, Manuela Carla, et al.
Publicado: (2022)

In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer
por: Milián, Lara, et al.
Publicado: (2022)

Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model
por: Casey, Sherelle L., et al.
Publicado: (2022)

A Critical Review of the Role of the Cannabinoid Compounds Δ(9)-Tetrahydrocannabinol (Δ(9)-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
por: Jones, Éamon, et al.
Publicado: (2020)

The effect of Δ9-tetrahydrocannabinol, cannabidiol, menthol and propofol on 5-hydroxytryptamine type 3 eeceptors--a computational approach
por: Schilbach, Andreas C, et al.
Publicado: (2015)

Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
por: Bartoli, Francesco, et al.
Publicado: (2021)

Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ(9)-tetrahydrocannabinol: a pilot study
por: Peters, Erica N., et al.
Publicado: (2021)

Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis
por: Tomko, Andrea M., et al.
Publicado: (2020)

Δ9-Tetrahydrocannabinol Prevents Methamphetamine-Induced Neurotoxicity
por: Castelli, M. Paola, et al.
Publicado: (2014)

Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants
por: Borges, Rosivaldo S., et al.
Publicado: (2013)

Comparative Study of Δ9-Tetrahydrocannabinol and Cannabidiol on Melanogenesis in Human Epidermal Melanocytes from Different Pigmentation Phototypes: A Pilot Study
por: Goenka, Shilpi
Publicado: (2022)

The Combination of Δ(9)-Tetrahydrocannabinol and Cannabidiol Suppresses Mitochondrial Respiration of Human Glioblastoma Cells via Downregulation of Specific Respiratory Chain Proteins
por: Rupprecht, Anne, et al.
Publicado: (2022)

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans
por: Nahler, Gerhard, et al.
Publicado: (2017)

Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide
por: Hassenberg, Christoph, et al.
Publicado: (2020)

Neuroprotective Effects of Cannabidiol but Not Δ(9)-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids
por: Landucci, Elisa, et al.
Publicado: (2021)

Study of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extraction FROM dried oral fluid spots (DOFS) and LC–MS/MS detection
por: Gorziza, Roberta, et al.
Publicado: (2021)

Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ(9)-tetrahydrocannabinol
por: Kanyo, Richard, et al.
Publicado: (2021)

Δ(9)-Tetrahydrocannabinol Differentially Alters Cannabidiol Efficacy in Recovery of Phonology and Syntax Following Damage to a Songbird Cortical-Like Brain Region
por: Hodges, Rachel M., et al.
Publicado: (2023)

The dimerization of Δ(9)-tetrahydrocannabinolic acid A (THCA-A)
por: Cuadari, Arben, et al.
Publicado: (2019)

Acute human exposure assessment to tetrahydrocannabinol (Δ(9)‐THC)
por: Arcella, Davide, et al.
Publicado: (2020)

Δ(9)-tetrahydrocannabinol discrimination: Effects of route of administration in mice
por: Marusich, Julie A., et al.
Publicado: (2023)

A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation
por: Solowij, Nadia, et al.
Publicado: (2014)

Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the “weed,” a pharmacodynamic discussion
por: Boggs, Douglas Lee, et al.
Publicado: (2016)

Chronic Adolescent Δ(9)-Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment
por: Murphy, Michelle, et al.
Publicado: (2017)

Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
por: Al-Ghezi, Zinah Zamil, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1s9dld3jr4v0sbpftep07hl67a